26629139|t|Consequence of dexmedetomidine on emergence delirium following sevoflurane anesthesia in children with cerebral palsy.
26629139|a|Children with cerebral palsy can demonstrate irritability following emergence from general anaesthesia. As well, an elevated rate of emergence delirium (ED) in children has been associated with the application of sevoflurane. The current study's intent is to administer dexmedetomidine, in a single dosage administration, at the initial phase of sevoflurane based anesthesia with regard to the occurrence and severity of ED in children afflicted with cerebral palsy. Participating in the study (American Society of Anesthesiologists I-II) are eighty children ranging in ages two through twelve years. They would be anaesthetised with sevoflurane based anesthesia while undergoing lower limb surgical procedures. The participants were equally distributed to either Group c or Group D. Group C was administered 10 ml saline 0.9%, and Group D was administered dexmedetomidine 0.5 mug kg(-1). Five minutes prior to commencement of the surgical procedures, the participants received the prescribed pharmaceutical dosages under the anesthesia of sevoflurane. In order to sustain the BIS values in a range of 45 and 55, at 60 second increments, endtidal sevoflurane concentrations (ETsev) were modified. After conclusion of the surgical procedures, in post anesthesia care unit (PACU), the frequency of ED was gauged with Aonos four point scale and the severity of ED was gauged with pediatric anesthesia emergence delirium scale upon admission (T0), after intervals of five minutes (T5), fifteen minutes (T15) and thirty minutes (T30). Extubation time, emergence time and length of at stay at the PACU were assessed. Relative to Group C, participants of Group D exhibited noticeably shortened times of emergence, extubation and PACU duration of stay. Prior to surgical incision, ETsev was elevated in the control group, (1.9+-0.2 vs 1.6+-0.3; P = 0.023) and amid the initial 20 minutes following the surgical incision (1.6+-0.2 vs 1.1+-0.2; P = 0.016). At intervals of commencement, T0, of five minutes (T5) and fifteen minutes T15, Group D exhibited lower occurrences and severity of ED than those participants in Group C. Dexmedetomidine, given as a bolus dose post induction, was effective in reducing the occurrence and severity of emergence delirium in children with cerebral palsy who were undergoing lower limb surgical procedures under sevoflurane anaesthesia. 
26629139	15	30	dexmedetomidine	Chemical	MESH:D020927
26629139	34	52	emergence delirium	Disease	MESH:D000071257
26629139	63	74	sevoflurane	Chemical	MESH:D000077149
26629139	103	117	cerebral palsy	Disease	MESH:D002547
26629139	133	147	cerebral palsy	Disease	MESH:D002547
26629139	164	176	irritability	Disease	MESH:D001523
26629139	252	270	emergence delirium	Disease	MESH:D000071257
26629139	272	274	ED	Disease	MESH:D000071257
26629139	332	343	sevoflurane	Chemical	MESH:D000077149
26629139	389	404	dexmedetomidine	Chemical	MESH:D020927
26629139	465	476	sevoflurane	Chemical	MESH:D000077149
26629139	540	542	ED	Disease	MESH:D000071257
26629139	570	584	cerebral palsy	Disease	MESH:D002547
26629139	753	764	sevoflurane	Chemical	MESH:D000077149
26629139	835	847	participants	Species	9606
26629139	976	991	dexmedetomidine	Chemical	MESH:D020927
26629139	1075	1087	participants	Species	9606
26629139	1159	1170	sevoflurane	Chemical	MESH:D000077149
26629139	1266	1277	sevoflurane	Chemical	MESH:D000077149
26629139	1415	1417	ED	Disease	MESH:D000071257
26629139	1477	1479	ED	Disease	MESH:D000071257
26629139	1517	1535	emergence delirium	Disease	MESH:D000071257
26629139	1751	1763	participants	Species	9606
26629139	2198	2200	ED	Disease	MESH:D000071257
26629139	2212	2224	participants	Species	9606
26629139	2237	2252	Dexmedetomidine	Chemical	MESH:D020927
26629139	2349	2367	emergence delirium	Disease	MESH:D000071257
26629139	2385	2399	cerebral palsy	Disease	MESH:D002547
26629139	2457	2468	sevoflurane	Chemical	MESH:D000077149
26629139	Negative_Correlation	MESH:D020927	MESH:D002547
26629139	Positive_Correlation	MESH:D000077149	MESH:D000071257
26629139	Negative_Correlation	MESH:D000077149	MESH:D020927
26629139	Association	MESH:D020927	MESH:D000071257

